BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 21195775)

  • 1. Antemortem differential diagnosis of dementia pathology using structural MRI: Differential-STAND.
    Vemuri P; Simon G; Kantarci K; Whitwell JL; Senjem ML; Przybelski SA; Gunter JL; Josephs KA; Knopman DS; Boeve BF; Ferman TJ; Dickson DW; Parisi JE; Petersen RC; Jack CR
    Neuroimage; 2011 Mar; 55(2):522-31. PubMed ID: 21195775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct MRI atrophy patterns in autopsy-proven Alzheimer's disease and frontotemporal lobar degeneration.
    Rabinovici GD; Seeley WW; Kim EJ; Gorno-Tempini ML; Rascovsky K; Pagliaro TA; Allison SC; Halabi C; Kramer JH; Johnson JK; Weiner MW; Forman MS; Trojanowski JQ; Dearmond SJ; Miller BL; Rosen HJ
    Am J Alzheimers Dis Other Demen; 2007 Dec-2008 Jan; 22(6):474-88. PubMed ID: 18166607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TDP-43 subtypes are associated with distinct atrophy patterns in frontotemporal dementia.
    Rohrer JD; Geser F; Zhou J; Gennatas ED; Sidhu M; Trojanowski JQ; Dearmond SJ; Miller BL; Seeley WW
    Neurology; 2010 Dec; 75(24):2204-11. PubMed ID: 21172843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathology-specific patterns of cerebellar atrophy in neurodegenerative disorders.
    Chen Y; Spina S; Callahan P; Grinberg LT; Seeley WW; Rosen HJ; Kramer JH; Miller BL; Rankin KP
    Alzheimers Dement; 2024 Mar; 20(3):1771-1783. PubMed ID: 38109286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI visual rating scales in the diagnosis of dementia: evaluation in 184 post-mortem confirmed cases.
    Harper L; Fumagalli GG; Barkhof F; Scheltens P; O'Brien JT; Bouwman F; Burton EJ; Rohrer JD; Fox NC; Ridgway GR; Schott JM
    Brain; 2016 Apr; 139(Pt 4):1211-25. PubMed ID: 26936938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medial temporal lobe atrophy on MRI differentiates Alzheimer's disease from dementia with Lewy bodies and vascular cognitive impairment: a prospective study with pathological verification of diagnosis.
    Burton EJ; Barber R; Mukaetova-Ladinska EB; Robson J; Perry RH; Jaros E; Kalaria RN; O'Brien JT
    Brain; 2009 Jan; 132(Pt 1):195-203. PubMed ID: 19022858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and Anatomical Imaging of Dementia With Lewy Bodies and Frontotemporal Lobar Degeneration.
    Duignan JA; Haughey A; Kinsella JA; Killeen RP
    Semin Nucl Med; 2021 May; 51(3):264-274. PubMed ID: 33402272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual assessment of atrophy on magnetic resonance imaging in the diagnosis of pathologically confirmed young-onset dementias.
    Likeman M; Anderson VM; Stevens JM; Waldman AD; Godbolt AK; Frost C; Rossor MN; Fox NC
    Arch Neurol; 2005 Sep; 62(9):1410-5. PubMed ID: 16157748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TDP-43-associated atrophy in brains with and without frontotemporal lobar degeneration.
    Buciuc M; Martin PR; Tosakulwong N; Murray ME; Petrucelli L; Senjem ML; Spychalla AJ; Knopman DS; Boeve BF; Petersen RC; Parisi JE; Reichard RR; Dickson DW; Jack CR; Whitwell JL; Josephs KA
    Neuroimage Clin; 2022; 34():102954. PubMed ID: 35168140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. White matter hyperintensities in autopsy-confirmed frontotemporal lobar degeneration and Alzheimer's disease.
    Desmarais P; Gao AF; Lanctôt K; Rogaeva E; Ramirez J; Herrmann N; Stuss DT; Black SE; Keith J; Masellis M
    Alzheimers Res Ther; 2021 Jul; 13(1):129. PubMed ID: 34256835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does TDP-43 type confer a distinct pattern of atrophy in frontotemporal lobar degeneration?
    Whitwell JL; Jack CR; Parisi JE; Senjem ML; Knopman DS; Boeve BF; Rademakers R; Baker M; Petersen RC; Dickson DW; Josephs KA
    Neurology; 2010 Dec; 75(24):2212-20. PubMed ID: 21172844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The power of neuroimaging biomarkers for screening frontotemporal dementia.
    McMillan CT; Avants BB; Cook P; Ungar L; Trojanowski JQ; Grossman M
    Hum Brain Mapp; 2014 Sep; 35(9):4827-40. PubMed ID: 24687814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frontotemporal lobar degeneration and dementia with Lewy bodies: clinicopathological issues associated with antemortem diagnosis.
    Yokota O
    Psychogeriatrics; 2009 Jun; 9(2):91-102. PubMed ID: 19604332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging correlates of pathology in corticobasal syndrome.
    Whitwell JL; Jack CR; Boeve BF; Parisi JE; Ahlskog JE; Drubach DA; Senjem ML; Knopman DS; Petersen RC; Dickson DW; Josephs KA
    Neurology; 2010 Nov; 75(21):1879-87. PubMed ID: 21098403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saccade abnormalities in autopsy-confirmed frontotemporal lobar degeneration and Alzheimer disease.
    Boxer AL; Garbutt S; Seeley WW; Jafari A; Heuer HW; Mirsky J; Hellmuth J; Trojanowski JQ; Huang E; DeArmond S; Neuhaus J; Miller BL
    Arch Neurol; 2012 Apr; 69(4):509-17. PubMed ID: 22491196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and Apo E4 in medial temporal lobe dementias. Oxford Project to Investigate Memory and Aging.
    Jobst KA; Barnetson LP; Shepstone BJ
    Int Psychogeriatr; 1998 Sep; 10(3):271-302. PubMed ID: 9785148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
    Jobst KA; Barnetson LP; Shepstone BJ
    Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel CSF biomarkers for frontotemporal lobar degenerations.
    Hu WT; Chen-Plotkin A; Grossman M; Arnold SE; Clark CM; Shaw LM; McCluskey L; Elman L; Hurtig HI; Siderowf A; Lee VM; Soares H; Trojanowski JQ
    Neurology; 2010 Dec; 75(23):2079-86. PubMed ID: 21048198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Senile onset frontotemporal lobar degeneration with TAR-DNA binding protein 43 proteinopathy primarily presenting with wasteful habits.
    Iwasaki Y; Mori K; Ito M; Tatsumi S; Mimuro M; Yoshida M
    Psychogeriatrics; 2013 Dec; 13(4):260-4. PubMed ID: 24289467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diverse limbic comorbidities cause limbic and temporal atrophy in lewy body disease.
    Sakurai K; Kaneda D; Morimoto S; Uchida Y; Inui S; Kimura Y; Cai C; Kato T; Ito K; Hashizume Y
    Parkinsonism Relat Disord; 2022 Dec; 105():52-57. PubMed ID: 36368094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.